Dr. Shaakir Hasan discusses disparities in bladder cancer diagnosis and treatment
Shaakir Hasan, DO, discusses socioeconomic characteristics associated with the diagnosis and management of bladder cancer.
Shaakir Hasan, DO, New York Proton Center, discusses socioeconomic characteristics associated with the diagnosis and management of bladder cancer. Hasan was the lead author on a research paper shared during the 2021 Genitourinary Cancers Symposium that focused on disparities in bladder cancer. Hasan and his coauthors wrote in their conclusion, "In the largest study of its kind, we report that several socioeconomic, racial, and gender factors are associated with the diagnosis of bladder cancer at a later stage, as well as the use of less cancer-directed treatments” (J Clin Oncol 39, 2021 (suppl 6; abstr 403). doi: 10.1200/JCO.2021.39.6_suppl.403).
Speaking of Urology Podcast: Dr. Ritch and Dr. Katz discuss new bladder cancer management app
December 7th 2021“It's not a replacement for clinical judgment, obviously. But at the end of the day, the idea is that it shows you what your next steps are based on what the American Urological Association and [Society of Urologic Oncology] guidelines are for non-muscle invasive bladder cancer,” Chad R. Ritch, MD, MBA, FACS.
Nadofaragene firadenovec shows durable efficacy in NMIBC
April 8th 2024"In this follow-up analysis of the phase 3 study, we demonstrated a sustained response to Adstiladrin treatment over 3 years, allowing more than half of the patients in the study to remain cystectomy free for at least 36 months,” says Colin P.N. Dinney, MD.
